Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean Donadieu

Showing results (91-100 of 174) with videos related to

Pageof 18
Sort By:
Blood|June 11, 2021
Heterozygous variants of CLPB are a cause of severe congenital neutropeniaJulia T Warren, Ryan R Cupo, Peeradol Wattanasirakul, et al.
Pediatric Blood & Cancer|July 21, 2009
Is pegfilgrastim safe and effective in congenital neutropenia? An analysis of the French Severe Chronic Neutropenia registryBlandine Beaupain, Thierry Leblanc, Oumédaly Reman, et al.
Blood Advances|May 8, 2026
Disease Extent, Not Lesion Location, Determines Relapse Risk in Single-System Skeletal Langerhans Cell HistiocytosisItziar Astigarraga, Helga Björk Arnardóttir, Oussama Abla, et al.
Blood|January 29, 2021
CXCR4 signaling controls dendritic cell location and activation at steady state and in inflammationCarmen Gallego, Mathias Vétillard, Joseph Calmette, et al.
Haematologica|April 12, 2012
Classification of and risk factors for hematologic complications in a French national cohort of 102 patients with Shwachman-Diamond syndromeJean Donadieu, Odile Fenneteau, Blandine Beaupain, et al.
Haematologica|December 17, 2009
Complications and treatment of patients with β-thalassemia in France: results of the National RegistryIsabelle Thuret, Corinne Pondarré, Anderson Loundou, et al.
Plos Medicine|August 19, 2007
Expansion of regulatory T cells in patients with Langerhans cell histiocytosisBrigitte Senechal, Gaelle Elain, Eric Jeziorski, et al.
British Journal of Haematology|March 20, 2020
Long-term efficacy and safety of 2CdA (cladribine) in extra-pulmonary adult-onset Langerhans cell histiocytosis: analysis of 23 cases from the French Histiocytosis Group and systematic literature reviewAntoine Néel, Mathieu Artifoni, Anne-Maelle Fontenoy, et al.
British Journal of Haematology|July 5, 2012
Outcome of children and adolescents with recurrent/refractory classical Hodgkin lymphoma, a study from the Société Française de Lutte contre le Cancer des Enfants et des Adolescents (SFCE)Stéphanie Gorde-Grosjean, Odile Oberlin, Thierry Leblanc, et al.
Blood|May 4, 2018
Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes diseaseOussama Abla, Eric Jacobsen, Jennifer Picarsic, et al.
Pageof 18

Showing results (91-100 of 174) with videos related to

Sort By:
Pageof 18
Blood|June 11, 2021
Heterozygous variants of CLPB are a cause of severe congenital neutropeniaJulia T Warren, Ryan R Cupo, Peeradol Wattanasirakul, et al.
Pediatric Blood & Cancer|July 21, 2009
Is pegfilgrastim safe and effective in congenital neutropenia? An analysis of the French Severe Chronic Neutropenia registryBlandine Beaupain, Thierry Leblanc, Oumédaly Reman, et al.
Blood Advances|May 8, 2026
Disease Extent, Not Lesion Location, Determines Relapse Risk in Single-System Skeletal Langerhans Cell HistiocytosisItziar Astigarraga, Helga Björk Arnardóttir, Oussama Abla, et al.
Blood|January 29, 2021
CXCR4 signaling controls dendritic cell location and activation at steady state and in inflammationCarmen Gallego, Mathias Vétillard, Joseph Calmette, et al.
Haematologica|April 12, 2012
Classification of and risk factors for hematologic complications in a French national cohort of 102 patients with Shwachman-Diamond syndromeJean Donadieu, Odile Fenneteau, Blandine Beaupain, et al.
Haematologica|December 17, 2009
Complications and treatment of patients with β-thalassemia in France: results of the National RegistryIsabelle Thuret, Corinne Pondarré, Anderson Loundou, et al.
Plos Medicine|August 19, 2007
Expansion of regulatory T cells in patients with Langerhans cell histiocytosisBrigitte Senechal, Gaelle Elain, Eric Jeziorski, et al.
British Journal of Haematology|March 20, 2020
Long-term efficacy and safety of 2CdA (cladribine) in extra-pulmonary adult-onset Langerhans cell histiocytosis: analysis of 23 cases from the French Histiocytosis Group and systematic literature reviewAntoine Néel, Mathieu Artifoni, Anne-Maelle Fontenoy, et al.
British Journal of Haematology|July 5, 2012
Outcome of children and adolescents with recurrent/refractory classical Hodgkin lymphoma, a study from the Société Française de Lutte contre le Cancer des Enfants et des Adolescents (SFCE)Stéphanie Gorde-Grosjean, Odile Oberlin, Thierry Leblanc, et al.
Blood|May 4, 2018
Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes diseaseOussama Abla, Eric Jacobsen, Jennifer Picarsic, et al.
Pageof 18